TABLE OF CONTENTS
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Glycomic Therapeutics Market – By Class
1.3.2 North America Glycomic Therapeutics Market – By Structures
1.3.3 North America Glycomic Therapeutics Market – By Indications
1.3.4 North America Glycomic Therapeutics Market – By Mode of Action
1.3.5 North America Glycomic Therapeutics Market – By Country
2. North America Glycomic Therapeutics Market– Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Glycomic Therapeutics Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Expert Opinion
5. North America Glycomic Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Wide Application in Various Disorders Followed by the Development of New Treatment Processes
5.1.2 Increasing Research and Development In the Field of Glycomic Therapeutics
5.2 Market Restraints
5.2.1 Shortage of Skilled Professionals and Lack of Research & Development laboratories in Developing Countries.
5.3 Market Opportunities
5.3.1 Wide Applications of Glycomics in Therapeutics
5.4 Future Trends
5.4.1 New Tools in Glycomics Research
5.5 Impact Analysis
6. Glycomic Therapeutics Market– North America Analysis
6.1 North America Glycomic Therapeutics Market Revenue Forecast and Analysis
6.1.1 North America: Glycomic Therapeutics Market, 2019-2028 (US$ Million)
7. North America Glycomic Therapeutics Market Revenue and Forecast to 2028– by Class
7.1 Overview
7.2 North America Glycomic Therapeutics Market, By Class 2022 & 2028 (%)
7.2.1 North America: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
7.3 Isolated
7.3.1 Overview
7.3.2 North America Isolated Revenue and Forecast to 2028 (US$ Million)
7.4 Synthetic
7.4.1 Overview
7.4.2 North America Synthetic - Revenue and Forecast to 2028 (US$ Million)
8. North America Glycomics Therapeutics Market Analysis and Forecasts To 2028 – By Indication
8.1 Overview
8.2 North America Glycomics Market, By Indication 2022 & 2028 (%)
8.2.1 North America: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
8.3 Thrombosis and Chemoprophylaxis
8.3.1 Overview
8.3.2 North America Thrombosis and chemoprophylaxis Revenue and Forecast to 2028 (US$ Million)
8.4 Anaemia
8.4.1 Overview
8.4.2 North America Anaemia Revenue and Forecast to 2028 (US$ Million)
8.5 Anti-adhesive and Anti-inflammatory
8.5.1 Overview
8.5.2 North America Anti-adhesive and Anti-inflammatory Revenue and Forecast to 2028 (US$ Million)
8.6 Cataract
8.6.1 Overview
8.6.2 North America Cataract Revenue and Forecast to 2028 (US$ Million)
8.7 Gaucher’s diseases
8.7.1 Overview
8.7.2 North America Gaucher’s diseases Revenue and Forecast to 2028 (US$ Million)
8.8 MPS-1 & IV
8.8.1 Overview
8.8.2 North America MPS-1 & IV Revenue and Forecast to 2028 (US$ Million)
8.9 Cancer
8.9.1 Overview
8.9.2 North America Cancer Revenue and Forecast to 2028 (US$ Million)
8.10 Alzheimer's
8.10.1 Overview
8.10.2 North America Alzheimer's Revenue and Forecast to 2028 (US$ Million)
8.11 Influenza Type A and B
8.11.1 Overview
8.11.2 North America Influenza Type A and B Revenue and Forecast to 2028 (US$ Million)
8.12 Others
8.12.1 Overview
8.12.2 North America Others Revenue and Forecast to 2028 (US$ Million)
9. North America Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Structures
9.1 Overview
9.2 North America Glycomic Therapeutics Market, By Structures 2022 & 2028 (%)
9.2.1 North America: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
9.2.1.1 North America: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
9.2.1.2 North America: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
9.2.1.3 North America: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
9.2.1.4 North America: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
9.3 Glycoproteins
9.3.1 Overview
9.3.2 North America Glycoproteins - Market Revenue and Forecast to 2028 (US$ Million)
9.4 Targeting Sialic Acid
9.4.1 Overview
9.4.2 North America Targeting Sialic Acid - Market Revenue and Forecast to 2028 (US$ Million)
9.4.3 Zanamivir
9.4.3.1 Overview
9.4.3.2 North America Zanamivir - Market Revenue and Forecast to 2028 (US$ Million)
9.4.4 Oseltamivir
9.4.4.1 Overview
9.4.4.2 North America Oseltamivir - Market Revenue and Forecast to 2028 (US$ Million)
9.5 Proteoglycans
9.5.1 Overview
9.5.2 North America Proteoglycans - Market Revenue and Forecast to 2028 (US$ Million)
9.6 Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans
9.6.1 Overview
9.6.2 North America Glycosylphosphatidylinositol (GPI)-Anchored Proteins and Heparin Based Glycans - Market Revenue and Forecast to 2028 (US$ Million)
9.7 Targeting Glycosaminoglycans
9.7.1 Overview
9.7.2 North America Targeting Glycosaminoglycans - Market Revenue and Forecast to 2028 (US$ Million)
9.7.3 Heparin
9.7.3.1 Overview
9.7.3.2 North America Heparin - Market Revenue and Forecast to 2028 (US$ Million)
9.7.4 Hyaluronan (HA)
9.7.4.1 Overview
9.7.4.2 North America Hyaluronan (HA)- Market Revenue and Forecast to 2028 (US$ Million)
9.7.5 Laronidase
9.7.5.1 Overview
9.7.5.2 North America Laronidase - Market Revenue and Forecast to 2028 (US$ Million)
9.7.6 Galsulfase (Naglazyme)
9.7.6.1 Overview
9.7.6.2 North America Galsulfase (Naglazyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.7.7 Hyaluronidase (Cumulase)
9.7.7.1 Overview
9.7.7.2 North America Hyaluronidase (Cumulase) - Market Revenue and Forecast to 2028 (US$ Million)
9.7.8 Others
9.7.8.1 Overview
9.7.8.2 North America Others - Market Revenue and Forecast to 2028 (US$ Million)
9.8 Targeting Glycosphingolipids
9.8.1 Overview
9.8.2 North America Targeting Glycosphingolipids - Market Revenue and Forecast to 2028 (US$ Million)
9.8.3 Imiglucerase (Cerezyme)
9.8.3.1 Overview
9.8.3.2 North America Imiglucerase (Cerezyme)- Market Revenue and Forecast to 2028 (US$ Million)
9.8.3.3 Agalsidase (Fabrazyme)
9.8.3.3.1 Overview
9.8.3.3.2 North America Agalsidase (Fabrazyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.8.3.4 N-butyl-deoxynojirimycin (DNJ)
9.8.3.4.1 Overview
9.8.3.4.2 North America N-butyl-deoxynojirimycin (DNJ) - Market Revenue and Forecast to 2028 (US$ Million)
9.8.4 Others
9.8.4.1 Overview
9.8.4.2 North America Others - Market Revenue and Forecast to 2028 (US$ Million)
9.9 Others
9.9.1 Overview
9.9.2 North America Others - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3 Acarbose
9.9.3.1 Overview
9.9.3.2 North America Acarbose - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3.3 Alglucosidase Alfa (Myozyme)
9.9.3.3.1 Overview
9.9.3.3.2 North America Alglucosidase Alfa (Myozyme) - Market Revenue and Forecast to 2028 (US$ Million)
9.9.3.4 Allosamidin
9.9.3.4.1 Overview
9.9.3.4.2 North America Allosamidin - Market Revenue and Forecast to 2028 (US$ Million)
9.9.4 Others
9.9.4.1 Overview
9.9.4.2 North America Others - Market Revenue and Forecast to 2028 (US$ Million)
10. North America Glycomic Therapeutics Market Revenue and Forecast to 2028 – by Mode of Action
10.1 Overview
10.2 North America Glycomic Therapeutics Market, By Mode of Action 2022 & 2028 (%)
10.2.1 North America: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
10.3 Inhibits Neuraminidase
10.3.1 Overview
10.3.2 North America Inhibits Neuraminidase - Market Revenue and Forecast to 2028 (US$ Million)
10.4 Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate
10.4.1 Overview
10.4.2 North America Inhibits Heparanase And Selectins And Blocks Interactions Between Growth Factors And Heparan Sulfate - Market Revenue and Forecast to 2028 (US$ Million)
10.5 Erythropoietin And Enzyme Replacement Therapy (ERT)
10.5.1 Overview
10.5.2 North America Erythropoietin And Enzyme Replacement Therapy (ERT) - Market Revenue and Forecast to 2028 (US$ Million)
10.6 Tissue Plasminogen Activator
10.6.1 Overview
10.6.2 North America Tissue Plasminogen Activator - Market Revenue And Forecasts To 2028 (US$ Million)
10.7 Inhibits Glucosylceramide Synthase
10.7.1 Overview
10.7.2 North America Inhibits Glucosylceramide Synthase - Market Revenue And Forecasts To 2028 (US$ Million)
10.8 Interleukin 1 And 2 And 3
10.8.1 Overview
10.8.2 North America Interleukin 1 And 2 And 3- Market Revenue And Forecasts To 2028 (US$ Million)
10.9 Beta And Gamma Interferons
10.9.1 Overview
10.9.2 North America Beta And Gamma Interferons- Market Revenue And Forecasts To 2028 (US$ Million)
10.10 Others
10.10.1 Overview
10.10.2 North America Others- Market Revenue And Forecasts To 2028 (US$ Million)
11. North America Glycomic Therapeutics Market Revenue and Forecasts to 2028 – Country Analysis
11.1 North America: Glycomic Therapeutics Market
11.1.1 Overview
11.1.2 North America: Glycomic Therapeutics Market, by Country, 2021 & 2028 (%)
11.1.3 US: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.1.1 Overview
11.1.3.1.2 US: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.1.3 US: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
11.1.3.1.4 US: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
11.1.3.1.4.1 US: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
11.1.3.1.4.2 US: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
11.1.3.1.4.3 US: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
11.1.3.1.4.4 US: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
11.1.3.1.5 US: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
11.1.3.1.6 US: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
11.1.3.2 Canada: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.2.1 Overview
11.1.3.2.2 Canada: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.2.3 Canada: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
11.1.3.2.4 Canada: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
11.1.3.2.4.1 Canada: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
11.1.3.2.4.2 Canada: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
11.1.3.2.4.3 Canada: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
11.1.3.2.4.4 Canada: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
11.1.3.2.5 Canada: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
11.1.3.2.6 Canada: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
11.1.3.3 Mexico: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.3.1 Overview
11.1.3.3.2 Mexico: Glycomic Therapeutics Market – Revenue and Forecast to 2028 (US$ Million)
11.1.3.3.3 Mexico: Glycomic Therapeutics Market, by Class, 2019-2028 (US$ Million)
11.1.3.3.4 Mexico: Glycomic Therapeutics Market, by Structure, 2019-2028 (US$ Million)
11.1.3.3.4.1 Mexico: Glycomic Therapeutics Market, by Targeting Sialic Acid, 2019-2028 (US$ Million)
11.1.3.3.4.2 Mexico: Glycomic Therapeutics Market, by Targeting Glycosaminoglycan, 2019-2028 (US$ Million)
11.1.3.3.4.3 Mexico: Glycomic Therapeutics Market, by Targeting Glycosphingolipids, 2019-2028 (US$ Million)
11.1.3.3.4.4 Mexico: Glycomic Therapeutics Market, by Others, 2019-2028 (US$ Million)
11.1.3.3.5 Mexico: Glycomic Therapeutics Market, by Indication, 2019-2028 (US$ Million)
11.1.3.3.6 Mexico: Glycomic Therapeutics Market, by Mode of Action, 2019-2028 (US$ Million)
12. Glycomic Therapeutics Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Glycomic Therapeutics Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 BioMarin Pharmaceutical Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Genzyme Corporation (Sanofi)
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Halozyme Therapeutics, Inc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bayer AG
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Alzheon, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 GlaxoSmithKline plc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 F. Hoffmann-La Roche Ltd
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms in Glycomic Therapeutics Market
LIST OF TABLES.
Table 1. North America Glycomic Therapeutics Market, Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Glycomic Therapeutics Market, by C lass – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 4. North America Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)
Table 5. North America Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)
Table 6. North America Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)
Table 7. North America Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)
Table 8. North America Glycomic Therapeutics Market, by Others– Revenue and Forecast to 2028 (USD Million)
Table 9. North America Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)
Table 10. US Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (USD Million)
Table 11. US Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)
Table 12. US Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)
Table 13. US Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)
Table 14. US Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)
Table 15. US Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (USD Million)
Table 16. US Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 17. US Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)
Table 18. Canada Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (USD Million)
Table 19. Canada Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (USD Million)
Table 20. Canada Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (USD Million)
Table 21. Canada Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (USD Million)
Table 22. Canada Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (USD Million)
Table 23. Canada Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (USD Million)
Table 24. Canada Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (USD Million)
Table 25. Canada Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (USD Million)
Table 26. Mexico Glycomic Therapeutics Market, by Class – Revenue and Forecast to 2028 (US$ Million)
Table 27. Mexico Glycomic Therapeutics Market, by Structure – Revenue and Forecast to 2028 (US$ Million)
Table 28. Mexico Glycomic Therapeutics Market, by Targeting Sialic Acid – Revenue and Forecast to 2028 (US$ Million)
Table 29. Mexico Glycomic Therapeutics Market, by Targeting Glycosaminoglycan – Revenue and Forecast to 2028 (US$ Million)
Table 30. Mexico Glycomic Therapeutics Market, by Targeting Glycosphingolipids – Revenue and Forecast to 2028 (US$ Million)
Table 31. Mexico Glycomic Therapeutics Market, by Others – Revenue and Forecast to 2028 (US$ Million)
Table 32. Mexico Glycomic Therapeutics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 33. Mexico Glycomic Therapeutics Market, by Mode of Action – Revenue and Forecast to 2028 (US$ Million)
Table 34. Organic Developments in the Glycomic Therapeutics Market
Table 35. Inorganic Developments in the Glycomic Therapeutics Market
Table 36. Glossary of Terms in Glycomic Therapeutics Market